• Title Postdoctoral Associate—Harris Lab
  • Education BSc in Biotechnology, Osmania University, India
    MSc in Biotechnology, Osmania University, India
    PhD in Biochemistry, CSIR-Indian Institute of Chemical Technology, India
  • Office K206
  • Area of Interest Mechanisms mediating neurodegenerative disorders and finding novel therapeutics

I am currently a Postdoctoral Associate in the laboratory of Dr. David A. Harris in the Department of Biochemistry at Boston University School of Medicine. I hold a B.Sc. and M.Sc. in Biotechnology from  Osmania University, India and a Ph.D. from CSIR-Indian Institute of Chemical Technology, where I studied the role of Alternatively spliced isoforms of alpha synuclein in human neurodegeneration under the guidance of Dr. Shasi V Kalivendi.

My research has focussed on understanding the pathways that lead to cell death in neurodegenerative disorders, identifying biomarkers for early detection and the development of novel therapeutics for neurodegenerative disorders.  During my PhD, I characterized the mechanisms through which an alternatively spliced isoform of alpha synuclein might aggravate the disease phenotype in Parkinson’s disease. I also identified a novel isoform of alpha synuclein which is the shortest one discovered till date. I then worked with Dr. Dutta and Dr. Monks at Wayne State University as a Postdoctoral Fellow where in I worked on the development of multifunctional dopamine agonists as a treatment for Parkinson’s and Alzheimer’s disease. My tenure at Scripps Research with Dr. Davis was focussed on the development of mitochondrial based therapeutics for Alzheimer’s disease.

Currently, my research In Dr. Harris’ lab focuses on identifying the molecular mechanisms by which alpha synuclein aggregates interact with cell surface receptors including the cellular prion protein.

View all people